Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Carboplatin vs Ifosfamide and Paclitaxel in Carcinosarcoma
NCT00954174Phase 3Unknown
- Sponsor
- GOG Foundation
- Start
- Aug 2009
- Primary completion
- Mar 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of carboplatin in uterine carcinosarcoma (UCS), ovarian carcinosarcoma (OCS), carcinosarcoma of the fallopian tube (MMMT) and 1 more, sponsored by GOG Foundation. Status: unknown.
02
Drugs
carboplatin
03
Conditions
uterine carcinosarcoma (UCS)ovarian carcinosarcoma (OCS)carcinosarcoma of the fallopian tube (MMMT)carcinosarcoma
Beyond the preview
Go deeper on NCT00954174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00954174.